Ovidrel (USA) (Choriogonadotropin alfa)
choriogonadotropin alfa 250 microgram/0.5 mL injection, 0.5 mL syringe · INJECTION · PBS code 14640M
RESTRICTEDWhat it costs
AU$112.8 PBS-determined price per 4 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2024-11-01.
- • Repeats: 5.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Infertility indications other than that of Assisted Reproductive Technology
Patient must not be undergoing treatment with medical services as described in items 13200, 13201, 13202 or 13203 of the Medicare Benefits Schedule; AND
Patient must not be undergoing simultaneous treatment with this drug through another PBS program listing; AND
Must be treated by an obstetrician/gynaecologist; or
Must be treated by a specialist in reproductive endocrinology/infertility; or
Must be treated by a urogynaecologist; or
Must be treated by an endocrinologist; or
Must be treated by a urologist.
The PBS prescription, whether it is to initiate or continue treatment, must be made out under the specialist's prescriber number.
Sponsor: Merck Healthcare Pty Ltd ABN 72 006 900 830
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.